Indian Pharma Sector Forecast 2014

Date: May 22, 2011
Pages: 105
Price:
US$ 800.00
Publisher: RNCOS E-Services Pvt. Ltd.
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery
ID: IDB19B15AEBEN
Leaflet:

Download PDF Leaflet

Indian Pharma Sector Forecast 2014
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,100.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00


Indian pharma industry has always been a leading industrial sector of the country, with a paralleled dominance of both domestic and foreign pharma companies. As a result of the vast potential held by the domestic industry, it was estimated to have generated revenue worth INR 655.5 Billion (US$ 13.1 Billion) in FY 2011. Growth of the industry can be attributed to prominent factors, such as growing middle class population, rapid urbanization, increase in lifestyle-related diseases, and increasing issuance of health insurance. Besides, the product patent regime has provided ample support to the industry to sustain its growth pace, despite the global economic downturn. Further, generic is emerging as one of the leading segments to be benefited by many drugs going off patent in due course of time.

According to our new research report “Indian Pharma Sector Forecast 2014”, Indian pharmaceutical industry is projected to show double-digit growth in near future owing to a rise in pharmaceutical outsourcing and rising investments by multinational companies. A large percentage of pharma products produced in India are exported, which has led the leading players to expand their reach into the Western nations. Due to the investments in R&D and the quest for more and more ANDA filings, the clinical trials market is expected to grow at blistering pace in coming years. For comprehensive outlook of the industry, we have done extensive research on various segments of the Indian pharma industry, such as the domestic & export market, branded & generics drugs, formulations & bulk drugs, etc.

The baseline for optimistic future outlook of the pharmaceutical market is improvement in the access to medicines to the Indian population. The focus of the industry will shift towards capitalizing the potential of tier-III and rural areas. Emerging sectors, such as bio-generics and pharma packaging will also pave way for the pharmaceutical market to continue its upward trend during the forecast period (FY 2012- FY 2014).

The report provides thorough statistical and analytical overview of the Indian pharmaceutical market. It contains information about past, present, and future trends, with focus on entire structure, composition, and working of the pharmaceutical market. The report extensively discusses opportunities and challenges expected to arise within and outside the pharmaceutical market. The report also analyzes emerging sectors, regulatory environment, and distribution system to identify strengths and weaknesses of the pharmaceutical market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. It also presents a brief overview of the demographics and healthcare profile to adjudge the pharmaceutical market in terms of demand, expenditure, and possible future direction.
1. ANALYST VIEW

2. MARKET DRIVERS

2.1 Macroeconomic & Demographic Profile
2.2 Product Patent Regime
2.3 Medical Infrastructure
2.4 Prevalence of Lifestyle-related Diseases

3. INDIAN PHARMACEUTICAL MARKET

3.1 Market Overview
3.2 Domestic & Exports Market
3.3 Future Outlook

4. MARKET SEGMENTATION

4.1 Branded & Generics
4.2 Type of Drugs
  4.2.1 Bulk Drugs/APIs
  4.2.2 Formulations
4.3 By Therapeutics
  4.3.1 Acute Segment
    4.3.1.1 Anti-Infectives
    4.3.1.2 Gastrointestinal
    4.3.1.3 Vitamins/Minerals/Nutrients
    4.3.1.4 Pain/Analgesics
    4.3.1.5 Dermatology
    4.3.1.6 Gynecology
    4.3.1.7 Respiratory
  4.3.2 Chronic Segment
    4.3.2.1 Cardiac
    4.3.2.2 Neuro/CNS
    4.3.2.3 Anti-Diabetic

5. DISTRIBUTION CHANNEL ANALYSIS

6. REGULATORY OVERVIEW

6.1 Industry Regulations
6.2 Government Initiatives
  6.2.1 Union Government
  6.2.2 State Government

7. EMERGING SECTORS

7.1 Biogenerics
7.2 Pharma Outsourcing Market
7.3 Bioinformatics
7.4 Clinical Trials
7.5 Pharma Packaging Industry

8. COMPETITIVE LANDSCAPE

8.1 Market Structure
8.2 M&A’s & Industry Developments
8.3 Key Players Analysis
  8.3.1 Ranbaxy Laboratories Limited
  8.3.2 Cipla Limited
  8.3.3 GlaxoSmithKline Pharmaceuticals Limited
  8.3.4 Nicholas Piramal India Limited
  8.3.5 Zydus Cadila

LIST OF FIGURES:

Figure 2-1: FDI Inflow (Billion US$), FY 2007 to FY 2011
Figure 2-2: FDI in Pharma Industry (Million US$), FY 2008 to FY 2010
Figure 2-3: Share of Mass & Specialty Therapies in Pharmaceutical Market (2006 & 2015)
Figure 3-1: Pharmaceutical Market (Billion INR), FY 2008 to FY 2011
Figure 3-2: Breakup of Pharmaceutical Market (%), FY 2010
Figure 3-3: Domestic Pharmaceutical Market (Billion INR), FY 2008 to FY 2011
Figure 3-4: Export of Drugs, Pharmaceuticals and Fine Chemicals (Billion INR), FY 2008 to FY 2011
Figure 3-5: Pharmaceutical Exports by Segment (%), FY 2011
Figure 3-6: Forecast for Domestic Pharmaceutical Market (Billion INR), FY 2012 to FY 2014
Figure 4-1: Forecast for Domestic Formulations Market by Drug Category (%), 2015
Figure 4-2: Bulk Drugs Export (Billion INR), FY 2008 to FY 2011
Figure 4-3: Domestic Formulations Market (Billion US$), FY 2008 to FY 2011
Figure 4-4: Formulations Export (Billion INR), FY 2008 to FY 2011
Figure 4-5: Domestic Pharmaceutical Market by Therapeutic Category (%), FY 2011
Figure 4-6: Anti-Infectives Market (Billion INR), FY 2011 & FY 2014
Figure 4-7: Gastrointestinal Drugs Market (Billion INR), FY 2011 & FY 2014
Figure 4-8: Vitamins/Minerals/Nutrients Market (Billion INR), FY 2011 & FY 2014
Figure 4-9: Pain/Analgesics Market (Billion INR), FY 2011 & FY 2014
Figure 4-10: Dermatology Market (Billion INR), FY 2011 & FY 2014
Figure 4-11: Gynecology Market (Billion INR), FY 2011 & FY 2014
Figure 4-12: Number of Asthma Patients (Million), 2005 & 2015
Figure 4-13: Respiratory Drugs Market (Billion INR), FY 2011 & FY 2014
Figure 4-14: Number of Coronary Heart Patients (Million), 2010 & 2015
Figure 4-15: Cardiac Drugs Market (Billion INR), FY 2011 & FY 2014
Figure 4-16: Neuro/CNS Drugs Market (Billion INR), FY 2011 & FY 2014
Figure 4-17: Number of Diabetes Patients (Million), 2007 & 2025
Figure 4-18: Anti-Diabetic Market (Billion INR), FY 2011 & FY 2014
Figure 5-1: Pharmaceutical Distribution Channel
Figure 7-1: Pharma Outsourcing Market (Billion US$), 2008-2010
Figure 7-2: BioInformatics Market (Billion INR), FY 2008 to FY 2011
Figure 7-3: Bioinformatics Market by Exports & Domestic Consumption (%), FY 2009
Figure 7-4: Number of Clinical Trials (2008-2010)
Figure 7-5: Forecast for Number of Clinical Trials (2011-2013)
Figure 7-6: Clinical Trials by Phase (%)
Figure 7-7: Clinical Trials by Therapy (%)
Figure 7-8: Clinical Trials Market (Million US$), 2008-2010
Figure 7-9: Forecast for Clinical Trials Market (Million US$), 2011-2013
Figure 7-10: Packaging Industry by Segment (%)
Figure 8-1: Share of Leading Companies in Domestic Pharmaceutical Market (2010)

LIST OF TABLES:

Table 2-1: Macroeconomic Overview (2009-2013)
Table 2-2: Demographic Characteristics (2009-2013)
Table 3-1: Top 10 Counties for Exports of Drugs, Pharmaceuticals & Fine Chemicals (Billion INR), FY 2010
Table 6-1: Launch of Patented Drugs by Product & Company
Table 8-1: Key Mergers & Acquisitions in Pharmaceutical Industry
Skip to top


Booming Pharma Sector in India US$ 1,100.00 Apr, 2010 · 105 pages
Indian Housing Sector Analysis US$ 800.00 Jan, 2012 · 140 pages
Indian Cosmetic Sector Analysis (2009-2012) US$ 800.00 Apr, 2011 · 70 pages

Ask Your Question

Indian Pharma Sector Forecast 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: